日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia

一项针对癌症相关性贫血的肝素单克隆抗体LY2787106的首次人体I期研究

期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-017-0427-x
Vadhan-Raj, Saroj; Abonour, Rafat; Goldman, Jonathan W; Smith, David A; Slapak, Christopher A; Ilaria, Robert L Jr; Tiu, Ramon V; Wang, Xuejing; Callies, Sophie; Cox, Joanne; Tuttle, Jay L; Lau, Yiu-Keung; Roeland, Eric J
单克隆抗体
肿瘤
肿瘤免疫
代谢
贫血
发表日期：2017
文献求助 收藏

Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway.

galunisertib（LY2157299 一水合物）是一种转化生长因子-β信号通路的小分子抑制剂，目前正在进行临床开发

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S86621
Herbertz Stephan, Sawyer J Scott, Stauber Anja J, Gueorguieva Ivelina, Driscoll Kyla E, Estrem Shawn T, Cleverly Ann L, Desaiah Durisala, Guba Susan C, Benhadji Karim A, Slapak Christopher A, Lahn Michael M
信号转导
发表日期：2015
文献求助 收藏

A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors

一项针对难治性实体瘤患者的新型抗癌化合物tasisulam钠（LY573636钠）的I期研究

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-011-1593-0
Simon, George R; Ilaria, Robert L Jr; Sovak, Mika A; Williams, Charles C; Haura, Eric B; Cleverly, Ann L; Sykes, Amanda K; Wagner, Margaret M; de Alwis, Dinesh P; Slapak, Christopher A; Miller, Mary A; Spriggs, David R
肿瘤
肿瘤免疫
发表日期：2011
文献求助 收藏